Moreover, a significant decrease in the heart weight (HW) by ~50% was noted in all STZ‐treated rats compared with their age‐matched CON (Figure 1C and Table 1) along with increases in the expression of ANF (Figure 1D), a biomarker gene for DCM. This evidence concerns the gene NPPA and familial dilated cardiomyopathy.